13 completed, 1 recruiting, 1 terminated. 9 Phase 1, 4 Not applicable, 1 Early Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Completed 9 |
| Not applicable | 4 | Completed 4 |
| Early Phase 1 | 1 | Terminated 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow Cefprozil: new trials by email Literature Review of Cefprozil trials Research Report on Cefprozil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP Ampicillin for Injection, Ceftriaxone for Injection, Amoxicillin - Community Acquired Pneumonia in Children | Phase 4 | Recruiting | Medical College of Wisconsin | 236 | 2024-08-22 | 2026-03-02 |
| Bioequivalence of Cefprozil Granule in Healthy Chinese Volunteers Cefprozil 125mg/5ml Susp; Cefprozil granule (125mg) - Healthy Volunteers | Phase 1 | Completed | The Affiliated Hospital of Qingdao University | 60 | 2018-09-11 | 2020-06-04 |
| Patients Response to Early Switch To Oral:Osteomyelitis Study oral antibiotics, intravenous antibiotics - Osteomyelitis | Early Phase 1 | Terminated | Julio Ramirez | 11 | 2014-03-06 | 2021-04-06 |
| Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fasting Conditions CEFPROZIL FOR ORAL SUSPENSION USP 250 mg/ 5 mL - Healthy | Not applicable | Completed | Ranbaxy Laboratories Limited | 35 | 2005-06-01 | 2008-10-23 |
| Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fed Conditions CEFPROZIL FOR ORAL SUSPENSION USP 250 mg/ 5 mL - Healthy | Not applicable | Completed | Ranbaxy Laboratories Limited | 32 | 2005-06-01 | 2008-10-23 |
| Bioequivalence Study of Cefprozil Tablets, USP 500 mg Undef Fed Conditions cefprozil 500mg tablets - Healthy | Not applicable | Completed | Ranbaxy Laboratories Limited | 26 | 2005-05-01 | 2008-10-23 |
| Bioequivalence Study of Cefprozil Tablets, USP 500 mg Under Fasting Conditions cefprozil 500mg tablets - Healthy | Not applicable | Completed | Ranbaxy Laboratories Limited | 27 | 2005-05-01 | 2008-10-23 |
| To Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Fed Conditions Cefprozil 250 mg/5 ml Oral Suspension (Sandoz, Austria), Cefzil (Cefprozil) 250 mg/5 ml Oral Suspension (Bristol-Myers Squibb, USA) - Healthy | Phase 1 | Completed | Sandoz | 24 | 2004-06-01 | 2017-03-29 |
| Cefprozil for Oral Suspension 250 mg/5 mL, Non-fasting Cefprozil for oral suspension 250 mg/5 mL, CEFZIL® for Oral Suspension 250 mg/5mL - Healthy | Phase 1 | Completed | Teva Pharmaceuticals USA | 26 | 2004-05-01 | 2024-08-20 |
| To Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Following a 10 ml Dose Fasting Conditions. Cefprozil 250 mg/5 ml Oral Suspension (Sandoz GmbH), Cefzil (Cefprozil) 250 mg/5 ml Oral Suspension (Bristol-Myers Squibb) - Healthy | Phase 1 | Completed | Sandoz | 20 | 2004-05-01 | 2017-03-29 |
| Cefprozil for Oral Suspension 250 mg/5 mL, Fasting Cefprozil for oral suspension 250 mg/5 mL, CEFZIL® for Oral Suspension 250 mg/5mL - Healthy | Phase 1 | Completed | Teva Pharmaceuticals USA | 26 | 2004-04-01 | 2024-08-20 |
| To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fasting Conditions Cefprozil 500 mg Tablets (Sandoz GmbH), Cefzil (Cefprozil) 500 mg Tablets (Bristol-Myers Squibb) - Healthy | Phase 1 | Completed | Sandoz | 26 | 2004-03-01 | 2017-03-29 |
| To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fed Conditions Cefprozil 500 mg Tablets (Sandoz, GmbH), Cefzil (Cefprozil) 500 mg Tablets (Bristol-Myers Squibb, USA) - Healthy | Phase 1 | Completed | Sandoz | 35 | 2004-03-01 | 2017-03-29 |
| Cefprozil 500 mg Tablets Under Fasting Conditions Cefzil® 500 mg tablets, Cefprozil 500 mg Tablets - Healthy | Phase 1 | Completed | Teva Pharmaceuticals USA | 38 | 2003-09-01 | 2024-08-20 |
| Cefprozil 500 mg Tablets Under Fed Conditions cefprozil, Cefzil® - Healthy | Phase 1 | Completed | Teva Pharmaceuticals USA | 39 | 2003-09-01 | 2024-08-20 |
Community-Acquired Pneumonia (1) · Osteomyelitis (1)
Ranbaxy Laboratories Limited (4) · Sandoz (4) · Teva Pharmaceuticals USA (4) · Julio Ramirez (1) · Medical College of Wisconsin (1) · The Affiliated Hospital of Qingdao University (1)
United States (6) · Canada (4) · China (1)
Gaetano Morelli, M.D. (2) · Magdy L. Shenouda, M.D. (2) · Steven Herrmann, M.D. (2) · David Seligson, MD (1) · Irwin Plisco, MD (1) · Julio Ramirez, MD (1) · Michelle Mitchell (1) · Walter Parham, M.D. (1) · Yu Cao, Doctor (1)
PMID 15276398, PMID 15840453, PMID 19588358, PMID 22530208, PMID 33340343, PMID 4902833, PMID 8948280